Stay updated on Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.

Latest updates to the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page
- Check7 days agoChange DetectedAdded a MedlinePlus Genetics topic: Type 2 diabetes. No deletions present.SummaryDifference0.3%

- Check15 days agoChange DetectedRemoved MedlinePlus Genetics topic: Type 2 diabetes.SummaryDifference0.3%

- Check22 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference3%

- Check29 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded a MedlinePlus Genetics topic on Type 2 diabetes and bumped the page revision to v3.0.2; removed the 'Back to Top' link (minor UI change).SummaryDifference0.5%

- Check50 days agoChange DetectedThe page has been updated to version 3.0.1, and the topic of Type 2 diabetes related to MedlinePlus Genetics has been removed.SummaryDifference0.5%

Stay in the know with updates to Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.